About Purigen Biosystems
Purigen Biosystems is a company based in Pleasanton (United States) founded in 2012 was acquired by Bionano Genomics in November 2022. Purigen Biosystems has raised $88.32 million across 7 funding rounds from investors including Agilent, HHS and Cota Capital. The company has 24 employees as of December 31, 2022. Purigen Biosystems operates in a competitive market with competitors including Nanopore, PacBio, Omniome, Complete Genomics and QuantuMDx, among others.
- Headquarter Pleasanton, United States
- Employees 24 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Purigen Biosystems
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$88.32 M (USD)
in 7 rounds
-
Latest Funding Round
$34.44 M (USD), Series C
Apr 02, 2021
-
Investors
Agilent
& 6 more
-
Employee Count
24
as on Dec 31, 2022
-
Acquired by
Bionano Genomics
(Nov 28, 2022)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Purigen Biosystems
Unlock access to complete
Unlock access to complete
Funding Insights of Purigen Biosystems
Purigen Biosystems has successfully raised a total of $88.32M across 7 strategic funding rounds. The most recent funding activity was a Series C round of $34.44 million completed in April 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Purigen Biosystems
Purigen Biosystems has secured backing from 7 investors, including institutional and venture fund investors. Prominent investors backing the company include Agilent, HHS and Cota Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Stage-agnostic venture capital investments are focused on US sectors.
|
Locked | Locked | Locked | |
|
Venture capital fund backed incubator focused on the healthcare startups
|
Locked | Locked | Locked | |
|
Corporate-backed venture capital firm focused on the healthcare sector
|
Locked | Locked | Locked |
Investor details for Purigen Biosystems
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Purigen Biosystems
Investment portfolio details for Purigen Biosystems
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Purigen Biosystems
Detailed financials for Purigen Biosystems
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Purigen Biosystems Comparisons
Peer comparison for Purigen Biosystems
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Purigen Biosystems
Purigen Biosystems operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Nanopore, PacBio, Omniome, Complete Genomics and QuantuMDx, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Nanopore-based electronic systems for single-molecule analysis are developed.
|
|
| Locked | Locked | Locked |
Instrument systems and software for single-molecule real-time sequencing are developed.
|
|
| Locked | Locked | Locked |
Genome sequencing platform is provided for clinical diagnostics.
|
|
| Locked | Locked | Locked |
DNA sequencing platform for human genome analysis is developed.
|
|
| Locked | Locked | Locked |
Handheld diagnostic and sequencing devices are developed for personalized healthcare.
|
|
| Locked | Locked | Locked |
Provider of genome analysis solutions to researchers and clinicians
|
Detailed competitors of Purigen Biosystems
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Purigen Biosystems
Complete news archive for Purigen Biosystems
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Purigen Biosystems
Purigen Biosystems was founded in 2012 and raised its 1st funding round 1 year after it was founded.
Purigen Biosystems is headquartered in Pleasanton, United States. It is registered at Pleasanton, California, United States.
Purigen Biosystems is a funded company, having raised a total of $88.32M across 7 funding rounds to date.
As of Dec 31, 2022, the latest employee count at Purigen Biosystems is 24.
Purigen Biosystems was founded in 2012 in Pleasanton, United States, within the biotechnology sector. Operations center on a platform utilizing isotachophoresis technology, originally developed in a Stanford University laboratory. Automated benchtop instrumentation and microfluidic chips are employed to purify and quantitate nucleic acids from diverse sources, including cancer samples. Purified DNA or RNA supports downstream applications such as next-generation sequencing, PCR, and genomic testing.
Purigen Biosystems has 7 investors. Key investors include Agilent, HHS, Cota Capital, 5AM Ventures, and Roche.